Scarlet Therapeutics Limited
13536278
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/07/2025
micro entity
Next accounts due
30/04/2027
Confirmation statement
Last: 27/07/2025
Due 10/08/2026
Industry
Officers
director · Since 12/08/2022
DIRECTOR
BRITISH · UNITED KINGDOM · Age 39
Also on 15 other boards
director · Since 12/08/2022
BIOTECH EXECUTIVE
BRITISH · SWITZERLAND · Age 57
director · Since 30/03/2026
BRITISH · UNITED KINGDOM · Age 55
Also on 3 other boards
Persons with Significant Control
Former PSCs
Professor Ashley Mark Toye
Ceased 12/08/2022
Science Creates Ventures
Ceased 12/08/2022
Scv Kcp Nominees Ltd
Ceased 21/06/2024
CompanyRankvs 1990+ SIC 72110 peers76
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2025
Net Worth
£491k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£381k
Working capital
Current Assets
£327k
Current Liabilities
£55k
Fixed Assets
£110k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 5.91 | -£703k |
| 2024 | 47.04 | -£26k |
| 2023 | 7.00 | +£1.2M |
| 2022 | 0.17 | — |
Derived from filed accounts. Not audited figures.